⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28472 | 0.96 | — | — | |
| SCHEMBL27897728 | 0.93 | — | — | |
| SCHEMBL28037945 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL1781764 | 0.93 | — | — | |
| Methane SCHEMBL2750066 | 0.93 | — | — | |
| Lithium SCHEMBL31720378 | 0.93 | — | — | |
| Ethane SCHEMBL16294625 | 0.90 | — | — | |
| Methyl Alcohol SCHEMBL28344666 | 0.90 | — | — | |
| Alcohol SCHEMBL28322673 | 0.84 | — | — | |
| SCHEMBL11831774 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102206487-B | Carboxylation beta-cyclodextrin modified low-toxicity functional quantum dot and preparation method thereof | JIANGSU MAIJIAN BIO TECH DEV CO LTD | 2013-08-21 | — | — | CN | claimed |
| CN-102206487-A | Carboxylation beta-cyclodextrin modified low-toxicity functional quantum dot and preparation method thereof | WUXI RONGXING TECHNOLOGY CO LTD | 2011-10-05 | — | — | CN | claimed |
| CN-109054795-A | A kind of preparation method of extra-low-permeability reservoir displacement of reservoir oil hydridization fluorine-containing surfactant | 成都理工大学 | 2018-12-21 | — | — | CN | disclosed |
| CN-108976153-A | Antibacterial hydrophilic compounds and application | 深圳大学 | 2018-12-11 | — | — | CN | disclosed |
| CN-103958474-B | (hetero) arylcyclopropylamine compounds as LSD1 inhibitors | 奥莱松基因组股份有限公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-105531258-A | Reactive antibacterial compound and preparation method thereof | UNIV SHENZHEN | 2016-04-27 | — | — | CN | disclosed |
| CN-102806047-B | Amino acid gemini surfactant and preparation method and application thereof | CHINA PETROLEUM & CHEMICAL | 2014-12-03 | — | — | CN | disclosed |
| CN-103958474-A | (hetero) arylcyclopropylamine compounds as LSD1 inhibitors | ORYZON GENOMICS SA | 2014-07-30 | — | — | CN | disclosed |
| CN-102206487-B | Carboxylation beta-cyclodextrin modified low-toxicity functional quantum dot and preparation method thereof | JIANGSU MAIJIAN BIO TECH DEV CO LTD | 2013-08-21 | — | — | CN | disclosed |
| CN-102806047-A | Amino acid gemini surfactant and preparation method and application thereof | CHINA PETROLEUM & CHEMICAL | 2012-12-05 | — | — | CN | disclosed |
| CN-102206487-A | Carboxylation beta-cyclodextrin modified low-toxicity functional quantum dot and preparation method thereof | WUXI RONGXING TECHNOLOGY CO LTD | 2011-10-05 | — | — | CN | disclosed |
| EP-0871623-A1 | 3-AZETIDINYLALKYLPIPERIDINES OR -PYRROLIDINES AS TACHYKININ ANTAGONISTS | Pfizer Research and Development Company, N.V./S.A. (IE) | 1998-10-21 | — | — | EP | disclosed |
| WO-1998022542-A2 | CHEMICAL FUNCTIONALIZATION OF SURFACES | IKONOS CORPORATION (US) | 1998-05-28 | — | — | WO | disclosed |
| US-5741790-A | Azetidines | PFIZER INC. (US) | 1998-04-21 | — | — | US | disclosed |
| EP-0791592-A2 | Azetidines | Pfizer Limited (GB) | 1997-08-27 | — | — | EP | disclosed |
| WO-1997027185-A1 | PIPERIDONE TACHYKININ ANTAGONISTS | PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) | 1997-07-31 | — | — | WO | disclosed |
| WO-1997025322-A1 | 3-AZETIDINYLALKYLPIPERIDINES OR -PYRROLIDINES AS TACHYKININ ANTAGONISTS | PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) | 1997-07-17 | — | — | WO | disclosed |
| CN-1154699-A | (Azetidin-1-ylalkyl) lactams as tachykinin antagonists | PFIZER LTD (IE) | 1997-07-16 | — | — | CN | disclosed |
| EP-0775132-A1 | (AZETIDIN-1-YLALKYL)LACTAMS AS TACHYKININ ANTAGONISTS | Pfizer Limited (GB) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996005193-A1 | (AZETIDIN-1-YLALKYL)LACTAMS AS TACHYKININ ANTAGONISTS | PFIZER LIMITED (GB) | 1996-02-22 | — | — | WO | disclosed |